Arrhythmia

Paroxysmal Supraventricular Tachycardia Treated With Novel Nasal Spray

Paroxysmal Supraventricular Tachycardia Treated With Novel Nasal Spray

Experimental nasal spray etripamil may benefit patients with paroxysmal supraventricular tachycardia.

Therapeutic Hypothermia May Improve Brain Function After Cardiac Arrest

Therapeutic Hypothermia May Improve Brain Function After Cardiac Arrest

Therapeutic hypothermia minimizes risk of brain injury in patients with cardiac arrest.

Long-Detection Programming in Single-Chamber Implantable Cardioverter Defibrillators Reduces Shocks and Pacing

Long-Detection Programming in Single-Chamber Implantable Cardioverter Defibrillators Reduces Shocks and Pacing

By

Long-detection programming improved survival, decreased the likelihood of hospitalization, and reduced therapy in patients with single-chamber ICDs.

Cardiac Arrest-Related Disability Reduced With Bystander CPR

Cardiac Arrest-Related Disability Reduced With Bystander CPR

Administration of CPR by a bystander after out-of-hospital cardiac arrest reduced disability in patients.

Left Atrial Appendage Isolation for Stable Sinus Rhythm

Left Atrial Appendage Isolation for Stable Sinus Rhythm

Although stable sinus rhythm was achieved in some patients after LAA isolation, embolic stroke and LAA thrombus formation was still problematic.

Dementia Risk in Atrial Fibrillation Increases With Delayed Anticoagulation

Dementia Risk in Atrial Fibrillation Increases With Delayed Anticoagulation

By

The delayed start of anticoagulation treatment for atrial fibrillation has been linked to an increase risk for dementia.

Newly Diagnosed Atrial Fibrillation Benefits From Rivaroxaban, Dabigatran

Newly Diagnosed Atrial Fibrillation Benefits From Rivaroxaban, Dabigatran

By

Direct oral anticoagulation reduced the risk of congestive heart failure admissions and all-cause mortality in both genders.

Wearable Cardioverter Defibrillators Safe, Effective for Pediatric Patients

Wearable Cardioverter Defibrillators Safe, Effective for Pediatric Patients

By

All arrhythmic episodes were successfully converted, and no deaths were reported.

Implantable Cardiac Devices, Abandoned Leads Pose Little Risk in MRI

Implantable Cardiac Devices, Abandoned Leads Pose Little Risk in MRI

By

Magnetic resonance imaging appears to be safe in patients with implantable cardiac devices and abandoned leads.

Sudden Cardiac Death/Ventricular Arrhythmia Risk in Atrial Fibrillation

Sudden Cardiac Death/Ventricular Arrhythmia Risk in Atrial Fibrillation

By

The annual risk of sudden cardiac death/ventricular arrhythmias was higher in patients with atrial fibrillation vs patients without atrial fibrillation.

Postoperative Atrial Fibrillation Predicted by Plasma Catecholamines

Postoperative Atrial Fibrillation Predicted by Plasma Catecholamines

The composite preoperative adrenergic plasma marker was associated with a 4-fold increase of developing postoperative atrial fibrillation.

Cardiac Magnetic Resonance Improves Diagnosis in Cardiac Arrest Survivors

Cardiac Magnetic Resonance Improves Diagnosis in Cardiac Arrest Survivors

By

Cardiac magnetic resonance was superior to transthoracic echocardiogram in identifying a pathologic substrate in patients with out-of-hospital cardiac arrest.

Does Azithromycin Therapy Increase Odds of Ventricular Arrhythmia?

Does Azithromycin Therapy Increase Odds of Ventricular Arrhythmia?

Researchers compared the risk of ventricular arrhythmia in patients taking azithromycin vs amoxicillin.

GI Bleeding Risk in Non-Valvular AF Lower With Apixaban

GI Bleeding Risk in Non-Valvular AF Lower With Apixaban

Gastrointestinal bleeding risk was assessed in patients given apixaban vs those given dabigatran or rivaroxaban.

Renin-Angiotensin System Inhibition Effect on Post-MI Mortality and New-Onset Atrial Fibrillation

Renin-Angiotensin System Inhibition Effect on Post-MI Mortality and New-Onset Atrial Fibrillation

By

Renin-angiotensin system inhibition was linked with a reduced 3-year risk of all-cause mortality in patients with congestive heart failure and atrial fibrillation.

Obesity Paradox Reported for CVD Death Outcomes in Atrial Fibrillation

Obesity Paradox Reported for CVD Death Outcomes in Atrial Fibrillation

By

A systematic review of BMI and major adverse events in AF concluded that further evidence is necessary to clarify the relationship between obesity and AF.

Do Non-Selective NSAIDs Increase Out-of-Hospital Cardiac Arrest Risk

Do Non-Selective NSAIDs Increase Out-of-Hospital Cardiac Arrest Risk

By

Researchers found that use of NSAIDs like naproxen and ibuprofen were linked to increased out-of-hospital cardiac arrest risk.

Preventing Supraventricular Tachyarrythmia With Sotalol Vs Alternative Antiarrhythmics

Preventing Supraventricular Tachyarrythmia With Sotalol Vs Alternative Antiarrhythmics

By

Researchers conducted a meta-analysis to compare the safety and efficacy of sotalol vs amiodarone or beta-blockers to prevent supraventricular arrhythmias.

Atrial Fibrillation Associated With Higher Mortality in STEMI

Atrial Fibrillation Associated With Higher Mortality in STEMI

By

Atrial fibrillation was associated with a higher risk of adjusted in-hospital mortality and bleeding complications after both PCI and CABG.

Higher CHADS<sub>2</sub> Score in Atrial Fibrillation Linked to Increased Dementia Risk

Higher CHADS2 Score in Atrial Fibrillation Linked to Increased Dementia Risk

By

CHADS2 scores in patients with atrial fibrillation are associated with increased risk of developing dementia.

Zika Virus Impacts Cardiovascular Health

Zika Virus Impacts Cardiovascular Health

Patients infected with Zika virus developed arrhythmia or heart failure, according to researchers.

Atrial Fibrillation Recurrence Not Reduced With Aggressive Blood Pressure Control

Atrial Fibrillation Recurrence Not Reduced With Aggressive Blood Pressure Control

By

Aggressive blood pressure treatment did not reduce atrial fibrillation recurrence after catheter ablation.

Dabigatran Bleeding Risk Stratified by Age in Atrial Fibrillation

Dabigatran Bleeding Risk Stratified by Age in Atrial Fibrillation

By

Compared with warfarin, there were lower rates of stroke with dabigatran 110 mg and 150 mg twice daily.

Nocturnal, Daytime Hypoglycemia Effects on Arrhythmia Risk in Type 1 Diabetes

Nocturnal, Daytime Hypoglycemia Effects on Arrhythmia Risk in Type 1 Diabetes

Compared with matched euglycemia, bradycardia was more frequent during nocturnal hypoglycemia.

Implantable Cardioverter-Defibrillators, Pacemakers Can Receive MRI

Implantable Cardioverter-Defibrillators, Pacemakers Can Receive MRI

None of the patients had device failure during the MRI; however, 6 patients did have atrial fibrillation or flutter but each case stopped on its own.

Implantable Cardioverter Defibrillator Shock-Related Healthcare Utilization Trends

Implantable Cardioverter Defibrillator Shock-Related Healthcare Utilization Trends

Nearly half of all implantable cardioverter defibrillator shock events utilized health care.

Heart Failure Treatment Outcomes With CRT Vary by PR Interval

Heart Failure Treatment Outcomes With CRT Vary by PR Interval

Cardiac resynchronization therapy with defibrillation correlated with reduced hospitalization or all-cause mortality and all-cause mortality in advanced systolic heart failure.

Atrial Fibrillation Hospitalization Rates

Atrial Fibrillation Hospitalization Rates

While hospitalization rates increased for patients with atrial fibrillation, mortality rates decreased.

Periprocedural Anticoagulation in Atrial Fibrillation: American College of Cardiology Decision Pathway

Periprocedural Anticoagulation in Atrial Fibrillation: American College of Cardiology Decision Pathway

By

The American College of Cardiology released a decision pathway for managing periprocedural anticoagulation in patients with nonvalvular atrial fibrillation

Sign Up for Free e-Newsletters